Skip to main content
ACET logo

Adicet Bio, Inc.

ACETNASDAQHealthcareBiotechnology

$3.94Today:- (-)1Y −68.94%

As of Oct 26, 2026 close

Market cap
$42.34M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$4.39$16.48
Volume (live)
-
Avg. volume (3M)
302.99K

Adicet Bio (ACET) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Adicet Bio reported total assets of $192.35M and total liabilities of $33.15M. Shareholders' equity was $159.21M, down 14.7% from $186.61M a year earlier. Total debt stood at $14.74M against $158.53M in cash and short-term investments, a net cash position of $143.79M. That puts debt-to-equity at 0.09, compared with 0.09 a year earlier.

Adicet Bio Balance Sheet Analysis

Values in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Adicet Bio, Inc. (ACET) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Jun 2017
Current Assets
Cash and Cash Equivalents38.9256.50159.71257.66277.5484.3310.617.0453.35
Short-Term Investments119.61119.810.000.000.0010.2851.79100.990.00
Cash & Short-Term Investments158.53176.30159.71257.66277.5494.6162.40108.0353.35
Accounts Receivable0.340.000.000.440.192.730.940.000.00
Inventory0.000.000.000.000.000.000.000.00136.39
Other Current Assets2.403.830.462.950.002.990.850.940.88
Total Current Assets160.93180.14162.27261.04282.44100.3464.19109.5354.23
Non-Current Assets
Property, Plant & Equipment (Net)28.4836.7544.2048.9835.0025.862.120.320.04
Long-Term Investments2.870.000.000.000.004.5310.590.08-541.50
Goodwill0.000.000.0019.4619.4620.090.000.00236.97
Intangible Assets0.000.000.000.000.001.190.000.00285.08
Other Non-Current Assets2.953.330.821.212.041.844.690.000.93
Total Non-Current Assets31.4340.0845.0269.6556.5053.5017.400.410.97
Total Assets192.36220.22207.30330.69338.94153.8481.59109.9455.19
Current Liabilities
Accounts Payable4.744.832.634.403.261.551.050.541.52
Short-Term Debt3.193.133.222.491.571.220.000.0014.47
Accrued Liabilities13.6111.436.937.112.665.73---
Deferred Revenue0.000.000.000.004.8113.9810.990.000.24
Other Current Liabilities13.6111.4313.4412.816.685.732.825.18-10.78
Total Current Liabilities21.5319.3919.2919.7116.3222.4814.875.725.50
Non-Current Liabilities
Long-Term Debt11.5514.1017.7018.5319.3820.420.003.11339.20
Deferred Tax Liabilities0.000.000.000.000.000.130.000.007.33
Other Non-Current Liabilities0.060.120.130.110.120.98116.20-3.09-346.53
Total Non-Current Liabilities11.6114.2217.8318.6519.4921.53127.090.02407.97
Total Liabilities33.1533.6137.1238.3535.8144.01141.955.745.50
Stockholders' Equity
Common Stock0.010.010.000.000.000.000.000.000.00
Retained Earnings-614.70-497.89-380.77-238.11-168.32-106.33-69.65-71.39-33.78
Accumulated Other Comprehensive Income0.100.020.000.000.000.020.02-0.04-5.11
Additional Paid-in Capital773.80684.48550.94530.45471.45216.139.26267.136.96
Shares Outstanding9.595.162.702.682.48----
Total Stockholders' Equity159.21186.61170.18292.34303.13109.83-60.37104.2049.69
Total Liabilities & Equity192.36220.22207.30330.69338.94153.8481.59109.9455.19

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Adicet Bio Balance Sheet

How much debt does Adicet Bio have?

Adicet Bio had total debt of $14.74M as of Dec 31, 2025, against $158.53M in cash and short-term investments. Its debt-to-equity ratio was 0.09. Total debt was $17.23M a year earlier.

What are Adicet Bio's total assets?

Adicet Bio reported total assets of $192.35M as of Dec 31, 2025, down 12.7% from $220.22M a year earlier. Total liabilities were $33.15M.

What is Adicet Bio's shareholders' equity?

Adicet Bio's shareholders' equity was $159.21M as of Dec 31, 2025, or about $16.61 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition